Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage II Prostate Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT07480044
What this trial is testing

A Phase II Clinical Two-Stage Study of Transcranial Magnetic Stimulation in Preventing Postoperative Delirium in Elderly Patients After Urological Surgery

Who this might be right for
Postoperative Delirium (POD)Prostate CancerKidney Tumor
Zhejiang University 220
Testing effectiveness (Phase 2)Ended earlyNCT01717898
What this trial is testing

Phase I/II Trial of Abiraterone Acetate + BEZ235 in Metastatic, Castration-Resistant Prostate Cancer

Who this might be right for
Castrate-resistant Prostate Cancer
Charles Ryan 6
Testing effectiveness (Phase 2)Looking for participantsNCT07354919
What this trial is testing

Axelopran for Advanced Cancer in Patients Receiving Opioids

Who this might be right for
Breast CancerLung CancerPancreas Cancer+1 more
HealthPartners Institute 34
Testing effectiveness (Phase 2)UnknownNCT00121095
What this trial is testing

Study of Samarium Sm-153 Lexidronam Combined With Docetaxel for Patients With Prostate Cancer

Who this might be right for
Prostatic Neoplasms
Cytogen Corporation 69
Not applicableStudy completedNCT00905086
What this trial is testing

Psychosocial Adjustment After Radiation Therapy in Patients With Cancer

Who this might be right for
Breast CancerCognitive/Functional EffectsColorectal Cancer+3 more
Case Comprehensive Cancer Center 80
Testing effectiveness (Phase 2)Ended earlyNCT00005072
What this trial is testing

Leuvectin in Treating Patients With Locally Recurrent Prostate Cancer

Who this might be right for
Prostate Cancer
Vical 25
Not applicableActive Not RecruitingNCT04189770
What this trial is testing

Lifestyle Behavior Influences Among African American Patients With Stage 0-III Prostate Cancer Survivors and Their Partners

Who this might be right for
Cancer SurvivorPartnerSpouse+9 more
M.D. Anderson Cancer Center 200
Large-scale testing (Phase 3)Study completedNCT00104741
What this trial is testing

Triptorelin, Flutamide, and External-Beam Radiation Therapy or External-Beam Radiation Therapy Alone in Treating Patients With Stage II or Stage III Prostate Cancer

Who this might be right for
Prostate Cancer
UNICANCER 378
Testing effectiveness (Phase 2)Study completedNCT00278070
What this trial is testing

Metronomic Oral Vinorelbine in Patients With Metastatic Tumors

Who this might be right for
Breast CancerNon Small Cell Lung CancerProstate Cancer
Hellenic Cooperative Oncology Group
Not applicableStudy completedNCT03160794
What this trial is testing

Prostate Cancer Subclinical Metastatic Ablative MR-guided Radiotherapy

Who this might be right for
Post Prostatectomy
University Health Network, Toronto 150
Testing effectiveness (Phase 2)Study completedNCT03199872
What this trial is testing

RV001V, a RhoC Anticancer Vaccine, Against Metastasis From Solid Tumours

Who this might be right for
Prostate Cancer
RhoVac APS 22
Testing effectiveness (Phase 2)Study completedNCT00069888
What this trial is testing

A Phase II Trial of Adjuvant Docetaxel in Patients At High Risk of Relapse Following Prostatectomy

Who this might be right for
Prostate Cancer
Sanofi 83
Testing effectiveness (Phase 2)UnknownNCT02935205
What this trial is testing

Enzalutamide and Indomethacin in Treating Patients With Recurrent or Metastatic Hormone-Resistant Prostate Cancer

Who this might be right for
Metastatic Prostate CarcinomaRecurrent Prostate CarcinomaStage IV Prostate Cancer
Mamta Parikh 38
Testing effectiveness (Phase 2)Study completedNCT02160353
What this trial is testing

Neo-adjuvant Abiraterone Prostate Study

Who this might be right for
High Risk Localised Prostate Carcinoma
Cancer Trials Ireland 45
Testing effectiveness (Phase 2)Ended earlyNCT00577356
What this trial is testing

Docetaxel and Immunotherapy Prior to Prostatectomy for High-Risk Prostate Cancer

Who this might be right for
Prostate Cancer
Benaroya Research Institute 6
Testing effectiveness (Phase 2)UnknownNCT00657982
What this trial is testing

Phase II Study of RAD001 in a Neoadjuvant Setting in Men With Intermediate or High Risk Prostate Cancer

Who this might be right for
Prostate Cancer
Sheba Medical Center 15
Not applicableLooking for participantsNCT06982469
What this trial is testing

High Dose Rate (HDR) Brachytherapy Salvage After Prostatectomy

Who this might be right for
Prostate CancerProstatectomyLocal Recurrence of Malignant Tumor of Prostate+2 more
Clinica Universidad de Navarra, Universidad de Navarra 20
Testing effectiveness (Phase 2)WithdrawnNCT02159690
What this trial is testing

A Phase II Neoadjuvant Study of Enzalutamide, Abiraterone Acetate, Dutasteride and Degarelix in Men With Localized Prostate Cancer Pre-prostatectomy

Who this might be right for
Prostate CancerLocalized Prostate Cancer
Kenneth Pienta, MD
Testing effectiveness (Phase 2)WithdrawnNCT01087580
What this trial is testing

Docetaxel + Prednisone With or Without Radiation for Castrate Resistant Prostate Cancer

Who this might be right for
PROSTATE CANCER
Northwestern University
Testing effectiveness (Phase 2)Study completedNCT00528866
What this trial is testing

Radiation Therapy, Androgen Suppression, and Docetaxel in Treating Patients With High-Risk Prostate Cancer Who Have Undergone Radical Prostatectomy

Who this might be right for
Prostate Cancer
Radiation Therapy Oncology Group 80
Next Page